SARA OVERLY: Open Payments
NPI 1245781186 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 14 payments from 10 companies in 2025. Trend: 2023 $16 · 2024 $19 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Lundbeck LLC | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Alkermes, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: INGREZZA, HETLIOZ, CAPLYTA, ABILIFY MAINTENA, Auvelity, INVEGA SUSTENNA, LYBALVI, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
